Published in Proc (Bayl Univ Med Cent) on January 01, 2000
Proteomic analysis of domestic pig pancreas during development using two-dimensional electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Lab Anim Res (2014) 0.75
Intrarenal pressure and irrigation flow with commonly used ureteric access sheaths and instruments. Cent European J Urol (2015) 0.75
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97
Infection of human cells by an endogenous retrovirus of pigs. Nat Med (1997) 5.71
Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science (1999) 4.44
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem (1988) 3.34
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Two sets of human-tropic pig retrovirus. Nature (1997) 2.74
Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol (1998) 2.59
An introduction to Ebola: the virus and the disease. J Infect Dis (1999) 2.33
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
The generation of transgenic pigs as potential organ donors for humans. Nat Med (1995) 1.86
Transgenic pigs and virus adaptation. Nature (1998) 1.74
Call for moratorium on xenotransplants. Nature (1998) 1.48
Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J Thorac Cardiovasc Surg (1998) 1.46
Delayed xenograft rejection. Immunol Today (1996) 1.23
Xenografting: ethical issues. J Med Ethics (1998) 1.15
Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation (2000) 1.10
Xenotransplantation at a crossroads: prevention versus progress. Nat Med (1996) 1.04
Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation (1998) 0.99
Critical ethical issues in clinical trials with xenotransplants. Lancet (1998) 0.94
Factors in xenograft rejection. Ann N Y Acad Sci (1999) 0.91
Quality of life improvements at one, two, and five years after liver transplantation. Transplantation (1995) 0.86
Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy. Transplantation (1988) 0.85
T cell-mediated xenograft rejection: specific tolerance is probably required for long term xenograft survival. Xenotransplantation (1998) 0.83
Physiological obstacles after xenotransplantation. Ann N Y Acad Sci (1998) 0.82
Xenoantigens and xenoantibodies: their modification. World J Surg (1997) 0.81
Xenotransplants: proceed with caution. Nature (1998) 0.79
Xenotransplantation: ethical acceptability. Transplant Proc (1997) 0.78
Basic anatomical and physiological differences between species should be considered when choosing combinations for use in models of hepatic xenotransplantation: an investigation of the guinea pig-to-rat combination. Transplantation (1998) 0.78
Xenotransplantation--caution, but no moratorium. Nat Med (1998) 0.78
Cross-species infection: no news is good news? Nat Med (1998) 0.78